The systolic slope of the blood velocity curve and the blood flow in the fetal thoracic aorta reflect the fetal cardiac function as well as the peripheral resistance. About half of the blood passing through the descending aorta will be distributed to the fetal part of the placenta which make this part of the circulation a target of special interest. The magnitude of the umbilical vein blood flow has. been regarded as a measure of the functional state of the fetal-placental unit. By combining real-time linear array ultrasonic technique and pulsed Doppler ultrasound it has been possible to quantify blood flow in the fetal descending aorta and the umbili-, cal vein (2) . During the last five years the combined method has been wi-; dely used and the methodological errors and limitations has been evaluated and discussed (2,5,13).
Clinical applications
Some discrepancy has been found between the descending aorta flow values-in the third trimester of normal gestation largely explained by the use of different high pass filters (5, 9) . The normal values, recently been report-, ed, are ranging from 235.0 + 73.8 ml/min/kg to 246.0 + 60 ml/min/kg (5,9, ! lo) . The flow values obtained from the intraabdominal· part of the umbiiical· vein has not been found to differ significantly between the different centers and are found to range from 98 + 52 ml/min/kg to 122 + 42 ml/min/kg (mean + 2SD) (2,4,5,6,^).
The method has been app^ed for pathophysiological studies in cases of intrauterine growth retardation. Confiicting resuits have been reported. JOUPPILA et al (6) found the blood flow in the umbilical vein below the normal range in 48% of the cases as a resuit of a narrowing of the vessel·. No changes were found in respect to the mean b^od f ^w in the descending aorta. GRIFFIN et al· (5) found that thoracic aorta veiocities fail· within the iower ^mits or beiow the normal· range in fetuses with growth retardation. GILL et al· (4) found in 9 patients with severe oiigohydramnios umbical· vein fiow va^es be^w the normal· range in ail· 5 infants, who iater on where found to be ^ght for gestational· age. Higher fiow va^es, on -the other hand, has been found in pregnancies with pathoiogical· pl·acentas suggesting that an impared piacental· function might be partiy compensated by an increased biood f^w (4) .
An inverse reiationship has been demonstrated between the biood fJLow in the uInbil·ical· vein and the postpartum hemogiobin concentration in the umbiiical· cord (8) and between the f^w ve^cities in the thoracic aorta and the hematocrit in fetuses with severe rhesus isoimmunization (5) . MARSAL et al· .(9) measured the aortic bLsod f^w during iabor in ciinically normal· pregnancies and found vaiues simiiar to that in uncompiicated term pregnancies. No difference was demonstrated between patients with intact or ruptured membranes.
The waveform of the veiocity curve is known to contain vaiua^e information J.Perinat.Med. 12(198*0 Copyright by Walter de Gruyter & Co., Berlin-New York about the dynamic condition of the cardiovascular system. The slope of the ascending part of the curve is a measure of the cardiac contraction force, while the rate of deceleration and the end diastolic flow is an accepted measure of the peripheral resistance. The waveform has been found to change in a characteristic fashion with increasing gestational age, one of which were an increase in the velocity in end diastole in the latter part of the third trimester (5) . STUART et al (12) using continous Doppler ultrasound found an increase in the ratio of peak systole to end diastole (the A/B ratio) with advancing gestational age also indicating a decline in the placental resistance during the third trimester. By a similar technique, GILES et al (3) found that the resistance in the umbilical arteries is increased above the normal limit in growth retarded fetuses. This is in accordance with findings by GRIFFIN et al (5) demonstrating an increased pulsatility index (PI) in the descending aorta in pregnancies with poor fetal growth. The observation of an increased vascular resistance in pregnancies complicated with growth retardation is further supported by the finding of an increased pulse propagation velocity along the aorta in those fetuses (11) as an increased systemic blood pressure earlier has been found to increase the pulse wave velocity in the arteriel system. In this context an important observation was recently done by CAMPBELL et al (1). In pregnancies complicated with hypertension, poor fetal growth and hypoxia a raised vascular resistance was demonstrated also on the maternal side of the placenta.
The reactivity of the human fetal cardiovascular system has been investigated in response to the maternal smoking in two investigations using the pulsed Doppler method (7,lo). The two studies are mutual contradictory as in the one study (7) no changes in either the aortic or the umbilical vein flow were found. In this investigation (7), no changes in either the maternal or the fetal heart rates were found as expected from other studies. In the other study (lo) a parallel increase in both the aortic blood flow velocity, the aortic diameter and also the mean blood flow was found within the first 2o min after smoking. This increase was followed by a similar increase in the umbilical blood flow by 55% 15 to 25 min after cessation of smoking. This increase however, was a result of an enhanced vessel diameter and not an increased blood flow velocity suggesting a greater resistance in the placental circulation after smoking.
Conclusion
Determination of blood flow in the human fetal descending aorta and the umbilical vein by real-time scanner combined with a pulsed Doppler has proved to be a reliable method. The method is not only valuable in evaluating the distribution and the magnitude of the blood flow. The method has also proved the utility during dynamic condition/ testing the reactivity of the fetal cardiovascular system. This might open new possibilities for testing the physiological or pathophysiological response of pharmacological agents for use in perinatal medicine. J.Perinat.Med.
